Skip to main content

Table 1 Patient demographics and clinical characteristics (N = 417 patients)

From: Quality of life and pain in patients with metastatic bone disease from solid tumors treated with bone-targeted agents– a real-world cross-sectional study from Switzerland (SAKK 95/16)

Median age (min., max.)

69 (30, 95)

Underlying tumor entity

N (%)

 Breast cancer

169 (41)

 Prostate cancer

106 (25)

 Lung cancer

62 (15)

 Other

80 (19)

Disease status

N (%)

 Progressing

112 (27)

 Stable

302 (72)

 Missing

3 (1)

ECOG performance status

N (%)

 0

140 (34)

 1

210 (50)

 2

53 (13)

 3

14 (3

Cancer treatments (multiple)

N (%)

 Chemotherapy

258 (62)

 Endocrine therapy

264 (63)

 Targeted treatments

100 (24)

 Immunotherapy

82 (20)

 Radiotherapy

251 (60)

 Radioisotope therapy

34 (8)

 Surgery

207 (50)

 Unknown

6 (1)

Employment status

N (%)

 Working part time

67 (16)

 Working full time

38 (9)

 Unemployed

46 (11)

 Retired

261 (63)

 Unknown

5 (1)